BRPI0606350A2 - usos do adapaleno - Google Patents

usos do adapaleno

Info

Publication number
BRPI0606350A2
BRPI0606350A2 BRPI0606350-0A BRPI0606350A BRPI0606350A2 BR PI0606350 A2 BRPI0606350 A2 BR PI0606350A2 BR PI0606350 A BRPI0606350 A BR PI0606350A BR PI0606350 A2 BRPI0606350 A2 BR PI0606350A2
Authority
BR
Brazil
Prior art keywords
adapalene
adaptalene
months
administration
enhance
Prior art date
Application number
BRPI0606350-0A
Other languages
English (en)
Inventor
Michael Graeber
Original Assignee
Galderma Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Res & Dev filed Critical Galderma Res & Dev
Publication of BRPI0606350A2 publication Critical patent/BRPI0606350A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

USOS DO ADAPALENO. A presente invenção propõe o uso do adapaleno na preparação de um medicamento tópico para administrar em um paciente de modo a reforçar sua resposta biológica no tratamento da acne vulgar, no qual o esquema de administração do medicamento compreende administrar uma quantidade terapeuticamente eficaz de adapaleno pelo menos uma vez a cada dois dias durante pelo menos 6 meses.
BRPI0606350-0A 2005-01-26 2006-01-23 usos do adapaleno BRPI0606350A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64730605P 2005-01-26 2005-01-26
PCT/EP2006/001140 WO2006079563A1 (en) 2005-01-26 2006-01-23 Adapalene for the long-term treatment of acne vulgaris

Publications (1)

Publication Number Publication Date
BRPI0606350A2 true BRPI0606350A2 (pt) 2009-06-16

Family

ID=36120099

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0606350-0A BRPI0606350A2 (pt) 2005-01-26 2006-01-23 usos do adapaleno

Country Status (13)

Country Link
US (3) US7642288B2 (pt)
EP (2) EP2540290B1 (pt)
JP (1) JP2008528538A (pt)
KR (1) KR20070098890A (pt)
CN (1) CN101106982A (pt)
AU (1) AU2006208705B9 (pt)
BR (1) BRPI0606350A2 (pt)
CA (1) CA2591062A1 (pt)
ES (2) ES2682669T3 (pt)
MX (1) MX2007007976A (pt)
RU (1) RU2419424C2 (pt)
WO (1) WO2006079563A1 (pt)
ZA (1) ZA200706151B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7820186B2 (en) 2001-12-21 2010-10-26 Galderma Research & Development Gel composition for once-daily treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt
DK1532974T3 (da) * 2002-03-12 2009-05-11 Galderma Res & Dev Sammensætning, der omfatter 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthsyre, til behandling af dermatologiske lidelser
AR065085A1 (es) * 2007-01-30 2009-05-13 Galderma Res & Dev Metodo para tratamiento prolongado del acne vulgaris

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU85849A1 (fr) * 1985-04-11 1986-11-05 Cird Derives benzonaphtaleniques,leur procede de preparation et leur application dans les domaines pharmaceutiques et cosmetiques
FR2753626B1 (fr) * 1996-09-20 1998-11-06 Centre International De Rech Dermatologiques Galderma Cird Galderma Nouvelles compositions topiques sous forme d'emulsion fluide h/e a forte teneur en glycol pro-penetrant
CH695515A5 (de) * 2002-03-08 2006-06-15 Alstom Technology Ltd Verfahren zur Bestimmung des elasto-plastischen Verhaltens von aus anisotropem Material bestehenden Bauteilen sowie Anwendung des Verfahrens.
DK1532974T3 (da) * 2002-03-12 2009-05-11 Galderma Res & Dev Sammensætning, der omfatter 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthsyre, til behandling af dermatologiske lidelser

Also Published As

Publication number Publication date
RU2007132165A (ru) 2009-03-10
EP2540290A1 (en) 2013-01-02
MX2007007976A (es) 2007-08-22
ZA200706151B (en) 2009-09-30
US7642288B2 (en) 2010-01-05
KR20070098890A (ko) 2007-10-05
EP2540290B1 (en) 2018-05-16
WO2006079563A1 (en) 2006-08-03
US20130041035A1 (en) 2013-02-14
CA2591062A1 (en) 2006-08-03
CN101106982A (zh) 2008-01-16
AU2006208705B9 (en) 2012-02-02
RU2419424C2 (ru) 2011-05-27
ES2682669T3 (es) 2018-09-21
ES2551011T3 (es) 2015-11-13
US20100069495A1 (en) 2010-03-18
US20080064755A1 (en) 2008-03-13
EP1845965A1 (en) 2007-10-24
AU2006208705A1 (en) 2006-08-03
AU2006208705B2 (en) 2011-08-11
EP1845965B1 (en) 2015-07-29
JP2008528538A (ja) 2008-07-31

Similar Documents

Publication Publication Date Title
BRPI0513200A (pt) uso de um anticorpo anti-igf-1r na preparação de um medicamento para tratamento combinado para malignidades não-hematológicas
BR0015048A (pt) Sal farmacêutico, medicamento, uso de pelo menos um sal de tramadol e formas de apresentação
BRPI0408490A (pt) composições que compreendem ácidos graxos e aminoácidos
BRPI0719115B8 (pt) sistema terapêutico transdérmico para administração de buprenorfina à pele
CY1111355T1 (el) Μειωση της ζαλης, μια παρενεργεια που συσχετιζεται με την θεραπεια πιρφενιδονης
CY1111478T1 (el) Ενδειξη δοσολογιας προγεστερονης στην αντιμετωπιση τραυματικης εγκεφαλικης βλαβης
EA201170018A1 (ru) Разагилин для изменения течения болезни паркинсона
HRP20130697T4 (hr) Supkutana formulacija protutijela anti-her2
BR0316906A (pt) administração do capsaicinoides
ECSP056076A (es) Sistema de suministro para droga y terapia celular
BR0316050A (pt) Métodos de tratar, controlar ou prevenir um câncer especìfico e doença associada com angiogênese indesejada e de reduzir ou evitar um efeito adverso associado com a administração de um segundo ingrediente ativo e com terapia de radiação, terapia hormonal, terapia biológica, ou imunoterapia em um paciente sofrendo de um câncer especìfico, composição farmacêutica e kit
EA200802012A1 (ru) Фармацевтические препараты в форме раствора для дозирующих ингаляторов под давлением
BRPI0415713A (pt) mio-inositol hexafosfato para uso tópico
ATE494889T1 (de) Pharmazeutische kombination mit 3- (3- dimethylamino-1-ethyl-2-methyl-propyl)-phenol und paracetamol
MX2009011900A (es) Curacion de herida diabetica.
BRPI0413129A (pt) medicamentos para inalação compreendendo betamiméticos e anticolinérgico
WO2004100893A3 (en) Methods for treatment of inflammatory diseases using ct-3 or analogs thereof
BR0313413A (pt) Uso da vacinação beta amilóide juntamente com um inibidor da cox-2 seletivo para o tratamento da doença de alzheimer
BRPI0519351A2 (pt) medicamentos para o tratamento ou prevenÇço de doenÇas fibràticas
ECSP077843A (es) Tratamiento o prevención del prurito
DE602007012904D1 (de) Neue 2',3'-methylidenacetyladenosine prodrugs zur
BR0116653A (pt) Medicamento contendo uma poliamina como substância ativa
AR048806A1 (es) Uso de cariofilenos en la elaboracion de medicamentos y tratamiento de afecciones corporales de inflamacion y dolor inflamatorio
BRPI0606350A2 (pt) usos do adapaleno
RU2009132502A (ru) Применение адапалена и пероксида бензоила для продолжительного лечения угрей обыкновенных

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL